• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Geron Corporation (GERN)

    -NasdaqGS
    3.85 Up 0.12(3.22%) 4:00PM EDT
    |After Hours : 3.85 0.00 (0.00%) 4:42PM EDT
    Add to Portfolio
    Prev Close:3.73
    Open:3.73
    Bid:3.71 x 200
    Ask:3.85 x 10000
    1y Target Est:5.50
    Beta:2.44
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:3.73 - 3.88
    52wk Range:1.60 - 4.49
    Volume:2,138,588
    Avg Vol (3m):3,992,210
    Market Cap:607.14M
    P/E (ttm):N/A
    EPS (ttm):-0.23
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    GERNUp 3.22%607.14M
    BMYUp 0.40%108.47B
    GSKUp 0.77%113.11B
    NVSUp 0.84%240.82B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):510.17
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.02
    Quarterly EPS Est (Mar-15) :-0.06
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-37.80

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback